AEGR-733: Interim Phase II data

Interim data from a double-blind, active-controlled Phase II trial in 84 patients showed that 4

Read the full 150 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE